NR

Niren Rasik Gandhi

Active Director Director DIN 08557034
DIN 08557034 First appointment Aug 2019 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2019
Shareholding value •••• Premium profile

About Niren Rasik Gandhi

Data last updated:

Niren Rasik Gandhi is a Director at Biomenovo Research Private Limited (since 2019). The company operates in Pharma. Biomenovo Research Private Limited reported revenue of ₹3.8 Lakh (FY 2025).

DIN 08557034
Primary Designation Director
Industry Pharma
First Appointment 26 Aug 2019
Oldest Company Age 11 yrs
Largest company Biomenovo Research Private Limited · ₹3.8 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Biomenovo Research Private Limited U74999MH2015PTC268658
Director26 Aug 20192015₹3.8 Lakh (FY 2025)Active

Board colleagues of Niren Rasik Gandhi

NameDINCompanyDesignation
Fei Gao08129852Biomenovo Research Private LimitedDirector

Directorship timeline

Open interactive timeline →
Biomenovo Research Private Limited
Premium access

Shareholding and investment profile for Niren Rasik Gandhi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Niren Rasik Gandhi

Niren Rasik Gandhi currently holds 1 directorship: Biomenovo Research Private Limited (Director, since 26 Aug 2019, revenue ₹3.8 Lakh (FY 2025)).

Niren Rasik Gandhi was first appointed on 26 Aug 2019 as Director at Biomenovo Research Private Limited.

The current boards of Niren Rasik Gandhi's companies include Fei Gao (Biomenovo Research Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available